Page last updated: 2024-10-27

gentamicin and Myelodysplastic Syndromes

gentamicin has been researched along with Myelodysplastic Syndromes in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Other Studies

1 other study available for gentamicin and Myelodysplastic Syndromes

ArticleYear
[Myelodysplastic syndrome, infectious endocarditis and cerebrovascular stroke].
    Medicina, 1998, Volume: 58, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Cerebral Hemorrhage; Endocarditis, Bacterial; Fatal Outcome; Female; Ge

1998